Home > Introduction

Introduction

This FHIR implementation guide is developed to support retrieving patient encounters, allergies, and clincal documents from acCDR.

This guide is based on FHIR R4.0.1.

Digital Health Information Exchange (DHIEX)

On January 1, 2021, an amendment to Ontario Regulation 329/04 (“O. Reg. 329/04” or the “regulation”) came into force to establish the DHIEX framework for interoperability specifications, as set out in sections 26 to 34 of the regulation. As a cornerstone of the Ministry of Health’s Digital First for Health Strategy, the DHIEX framework is intended to guide and support adoption of modern interoperability specifications for seamless access to integrated records of personal health information. In accordance with the regulation, Ontario Health is required to, subject to the review and approval of the Minister, establish, maintain and amend interoperability specifications for digital health assets selected, developed or used by health information custodians.

In accordance with O. Reg. 329/04, a health information custodian is required to ensure that every digital health asset that it selects, develops or uses complies with every applicable interoperability specification, as it may be amended from time to time, within the time period set out in the specification. Compliance with this requirement does not relieve a health information custodian of its obligation to comply with the other provisions of PHIPA and its regulations.

Background

A key component of the Ontario Health's Clinical Data Foundation is the acute and community Clinical Data Repository (acCDR). acCDR stores and provide a record of the care which has been and is currently being provided to clients of the Ontario health system.

Content and Organization

The implementation guide is organized into the following sections:

This specification is fully copyright protected by the owner. The owner has the exclusive right to make copies of this specification. No alterations, deletions or substitutions may be made without the prior written consent of the owner. No part of it may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, email or any information storage and retrieval system, without the prior written consent of the owner.

This specification contains information for which copyright is held by Health Level Seven Inc. Implementors of the standards (those developing software or otherwise making use of the specification) are required to be members of either Health Level Seven Inc., HL7 Canada or one of the other HL7 affiliates. There is no such membership requirement for individuals and organizations which merely install or use software with built-in HL7 interfaces.

HL7® and FHIR® are registered trademarks of Health Level Seven, Inc. (https://www.hl7.org).

LOINC® is a registered trademark of the Regenstrief Institute, Inc. (http://regenstrief.org)

This material includes SNOMED Clinical Terms® (SNOMED CT®) (https://www.snomed.org/snomed-ct/) which is used by permission SNOMED International. All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists.

“SNOMED” and “SNOMED CT” are registered trademarks of SNOMED International (https://www.snomed.org/).